Daniel Mueller

2.4k total citations
42 papers, 1.4k citations indexed

About

Daniel Mueller is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Mueller has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Mueller's work include Cancer Immunotherapy and Biomarkers (9 papers), MicroRNA in disease regulation (5 papers) and Cancer Genomics and Diagnostics (5 papers). Daniel Mueller is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), MicroRNA in disease regulation (5 papers) and Cancer Genomics and Diagnostics (5 papers). Daniel Mueller collaborates with scholars based in Germany, United States and Switzerland. Daniel Mueller's co-authors include Anja‐Katrin Bosserhoff, Michael Rehli, Zaza Katsarava, Mark Obermann, Hans‐Christoph Diener, Min‐Suk Yoon, Tanja Rothhammer, Simone Braig, P. Dommes and Elke R. Gizewski and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Daniel Mueller

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Mueller Germany 16 513 409 354 211 193 42 1.4k
Young‐Min Lim South Korea 24 404 0.8× 108 0.3× 368 1.0× 83 0.4× 591 3.1× 100 1.7k
August Yue Huang United States 21 641 1.2× 187 0.5× 125 0.4× 78 0.4× 252 1.3× 40 1.6k
Didier Martin Belgium 34 517 1.0× 149 0.4× 816 2.3× 157 0.7× 636 3.3× 135 3.2k
Zhaoyang Yang China 25 496 1.0× 256 0.6× 525 1.5× 40 0.2× 74 0.4× 87 2.4k
Kasthuri Kannan United States 15 665 1.3× 221 0.5× 66 0.2× 120 0.6× 99 0.5× 32 1.4k
Gérald Raverot France 43 1.0k 2.0× 499 1.2× 180 0.5× 137 0.6× 478 2.5× 181 5.6k
Sung‐Min Kim South Korea 25 384 0.7× 64 0.2× 435 1.2× 196 0.9× 552 2.9× 94 1.7k
Kathleen A. Leppig United States 23 662 1.3× 123 0.3× 140 0.4× 54 0.3× 310 1.6× 57 2.0k
M.H. Breuning Netherlands 29 1.1k 2.2× 189 0.5× 408 1.2× 190 0.9× 229 1.2× 60 2.6k
Fang Jiang China 20 1.2k 2.3× 130 0.3× 78 0.2× 121 0.6× 120 0.6× 60 2.0k

Countries citing papers authored by Daniel Mueller

Since Specialization
Citations

This map shows the geographic impact of Daniel Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Mueller more than expected).

Fields of papers citing papers by Daniel Mueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Mueller. The network helps show where Daniel Mueller may publish in the future.

Co-authorship network of co-authors of Daniel Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Mueller. A scholar is included among the top collaborators of Daniel Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Mueller. Daniel Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Al-Batran, S-E., Daniel Mueller, Akin Atmaca, et al.. (2023). A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology. ESMO Open. 8(5). 101623–101623. 5 indexed citations
3.
Mueller, Daniel, et al.. (2022). Searching for Culture in “Cultural Capital”: The Case for a Mixed Methods Approach to Production Facility Siting. Frontiers in Energy Research. 9. 3 indexed citations
4.
5.
Vogel, Arndt, Thorsten Oliver Goetze, Michael Geißler, et al.. (2021). The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 39(15_suppl). TPS4159–TPS4159. 1 indexed citations
6.
7.
8.
Mueller, Daniel, et al.. (2020). Quantifying the community capitals framework: Strategic application of the community assets and attributes model. Community Development. 51(5). 535–555. 22 indexed citations
9.
10.
Mueller, Daniel, et al.. (2018). Factor substitution in Swiss manufacturing: empirical evidence using micro panel data. Zeitschrift für schweizerische Statistik und Volkswirtschaft/Schweizerische Zeitschrift für Volkswirtschaft und Statistik/Swiss journal of economics and statistics. 154(1). 6–6. 10 indexed citations
11.
Mueller, Daniel, et al.. (2013). A model for estimating energy consumption based on resources utilization. 42. 1–6. 3 indexed citations
12.
Mueller, Daniel, Benno Torgler, & Eric M. Uslaner. (2012). A comment on 'inherited trust and growth'. Economics bulletin. 32(2). 1481–1488. 12 indexed citations
13.
Wallner, Susanne, et al.. (2012). Deregulation of protein methylation in melanoma. European Journal of Cancer. 49(6). 1305–1313. 42 indexed citations
14.
Hansen, Niels, Mark Obermann, Nurcan Üçeyler, et al.. (2011). Klinische Anwendung schmerzevozierter Potenziale. Der Schmerz. 26(1). 8–15. 5 indexed citations
15.
Mueller, Daniel & Anja‐Katrin Bosserhoff. (2010). MicroRNA miR‐196a controls melanoma‐associated genes by regulating HOX‐C8 expression. International Journal of Cancer. 129(5). 1064–1074. 101 indexed citations
16.
Braig, Simone, Daniel Mueller, Tanja Rothhammer, & Anja‐Katrin Bosserhoff. (2010). MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cellular and Molecular Life Sciences. 67(20). 3535–3548. 108 indexed citations
17.
Mueller, Daniel & Anja‐Katrin Bosserhoff. (2010). The evolving concept of ‘melano‐miRs’– microRNAs in melanomagenesis. Pigment Cell & Melanoma Research. 23(5). 620–626. 21 indexed citations
18.
Mueller, Daniel & Anja‐Katrin Bosserhoff. (2009). Role of miRNAs in the progression of malignant melanoma. British Journal of Cancer. 101(4). 551–556. 87 indexed citations
19.
Markewitz, Peter, et al.. (2003). IKARUS - Energy scenarios until 2030; IKARUS - Energieszenarien bis 2030. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 3 indexed citations
20.
Oechsner, Matthias, et al.. (2000). Pleural fibrosis associated with dihydroergocryptine treatment. Acta Neurologica Scandinavica. 101(4). 283–285. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young‐Min Lim Breakdown of academic impact, for papers by August Yue Huang Breakdown of academic impact, for papers by Didier Martin Breakdown of academic impact, for papers by Zhaoyang Yang Breakdown of academic impact, for papers by Kasthuri Kannan Breakdown of academic impact, for papers by Gérald Raverot Breakdown of academic impact, for papers by Sung‐Min Kim Breakdown of academic impact, for papers by Kathleen A. Leppig Breakdown of academic impact, for papers by M.H. Breuning Breakdown of academic impact, for papers by Fang Jiang
Rankless by CCL
2026